Clinical trial
A Multi-Center, Prospective, Pragmatic, Randomized, Controlled Clinical Trial to Compare HF10 Therapy to Conventional Medical Management in the Treatment of Non-Surgical Refractory Back Pain
NCT03680846 is registered in ClinicalTrials.gov with Nevro Corp as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center, Prospective, Pragmatic, Randomized, Controlled Clinical Trial to Compare HF10 Therapy to Conventional Medical Management in the Treatment of Non-Surgical Refractory Back Pain
- Lead sponsor
- Nevro Corp
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 5, 2018
- Completion date
- May 9, 2022
- Enrollment
- 211 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.